Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is manifested by an acute respiratory distress syndrome (ARDS) with intense inflammation and endothelial dysfunction leading to particularly severe hypoxemia. We hypothesized that an impaired hypoxic pulmonary vasoconstrictio...
Main Authors: | Driss Laghlam, Ghilas Rahoual, Julien Malvy, Philippe Estagnasié, Alain Brusset, Pierre Squara |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.655763/full |
Similar Items
-
Development and validation of two chromatographic methods for the simultaneous determination of raubasine and almitrine besmesylate in pharmaceutical dosage form
by: Mai A. Basha, et al.
Published: (2013-06-01) -
Unraveling the impact of nitric oxide, almitrine, and their combination in COVID-19 (at the edge of sepsis) patients: a systematic review
by: Ying Wang, et al.
Published: (2024-01-01) -
Post-operative Right Ventricular Failure After Cardiac Surgery: A Cohort Study
by: David Levy, et al.
Published: (2021-06-01) -
Inhaled nitric oxide for ARDS due to sickle cell disease
by: M Oppert, et al.
Published: (2004-03-01) -
Acute Cor Pulmonale in COVID-19-Related ARDS
by: Pierre Huette, MD, et al.
Published: (2020-07-01)